Wentworth Kory James Insider Trades

Insider Trading History

Track insider trading activity for Wentworth Kory James. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $833k 119,010 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$32.4k 2,500 shares
$12.95
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $851k 121,510 shares
Last Trade
Mar 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$148k 11,388 shares
$13.02
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $930k 132,898 shares
Last Trade
Mar 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$66.2k 5,089 shares
$13.00
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $966k 137,987 shares
Last Trade
Mar 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$97.9k 7,988 shares
$12.25
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $1.02M 145,975 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$67.2k 5,712 shares
$11.76
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $1.06M 151,687 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$34.3k 2,939 shares
$11.66
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $466k 66,600 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$795k 66,600 shares
$11.93
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $1.08M 154,626 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$532k 44,600 shares
$11.93
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $770k 110,026 shares
Last Trade
Nov 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$88.9k 8,910 shares
$9.98
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $833k 118,936 shares
Last Trade
Sep 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.42k 1,734 shares
$5.43
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $140k 20,023 shares
Last Trade
Apr 03, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$89.3k 11,134 shares
$8.02
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $845k 120,670 shares
Last Trade
Apr 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$89.3k 11,134 shares
$8.02
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $767k 109,536 shares
Last Trade
Mar 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$19k 1,784 shares
$10.67
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $779k 111,320 shares
Last Trade
Mar 03, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$57.6k 4,929 shares
$11.68
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $814k 116,249 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$756k 63,300 shares
$11.94
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $552k 78,849 shares
Last Trade
Dec 02, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 5,000 shares
$20.32
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $517k 73,849 shares
Last Trade
Dec 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$100k 5,000 shares
$20.00
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $218k 31,157 shares
Last Trade
Dec 02, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 5,000 shares
$20.32
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $253k 36,157 shares
Last Trade
Nov 29, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.9k 1,000 shares
$19.89
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Chief Financial Officer
Holding Value $524k 74,849 shares
Last Trade
Nov 29, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.9k 1,000 shares
$19.89
$7.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up